Radius Health Inc.

NASDAQ:RDUS   3:59:53 PM EDT
14.56
-0.48 (-3.19%)
Products

Radius Health Announces Plans For Global Prader-Willi Syndrome Pivotal Study

Published: 07/22/2021 13:45 GMT
Radius Health Inc. (RDUS) - Radius Health Announces Plans for Global Prader-willi Syndrome Pivotal Study.
Radius Health Inc - FDA Type C Meeting Minutes Provide Clarity on Phase 2/3 Study Design for Rad011.
Radius Health Inc - Study Initiation Targeted by End of Year Or Early Q1 of 2022.
Radius Health Inc - Based on Results, a Single Well Controlled Study Could Serve As Basis for Marketing Approval.
Radius Health Inc - Based on Feedback Received, Radius Plans on Initiating a Pivotal Phase 2/3 Global Study for Patients With Pws.